Wale J, Fitzgerald J
Proc R Soc Med. 2010; 70(Suppl 5):45-7.
PMID: 20919348
PMC: 1542847.
Andersen K
Br Heart J. 1982; 48(2):149-55.
PMID: 7093084
PMC: 481219.
DOI: 10.1136/hrt.48.2.149.
Ihlen H, Simonsen S, Welzel D
Eur J Clin Pharmacol. 1984; 27(1):29-34.
PMID: 6489425
Lawrence D, Sahay J, Chatterjee S, Cruickshank J
Eur J Clin Pharmacol. 1982; 22(6):501-9.
PMID: 6127219
DOI: 10.1007/BF00609622.
Northcote R, Ballantyne D
Br Med J (Clin Res Ed). 1986; 293(6539):97-9.
PMID: 3089433
PMC: 1340838.
DOI: 10.1136/bmj.293.6539.97.
Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
McLeod A, Knopes K, SHAND D, Williams R
Br J Clin Pharmacol. 1985; 19(1):13-20.
PMID: 2858214
PMC: 1463791.
DOI: 10.1111/j.1365-2125.1985.tb02607.x.
Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
De Plaen J, Amery A, Reybrouck T
Eur J Clin Pharmacol. 1976; 10(5):297-303.
PMID: 789082
DOI: 10.1007/BF00565617.
Effect of atenolol (ICI 66 082) on coronary haemodynamics in man.
Simonsen S
Br Heart J. 1977; 39(11):1210-16.
PMID: 588377
PMC: 483398.
DOI: 10.1136/hrt.39.11.1210.
Haemodynamic effects of atenolol in patients with coronary artery disease.
Robinson C, Jackson G, Fisk C, Jewitt D
Br Heart J. 1978; 40(1):22-8.
PMID: 341928
PMC: 481969.
DOI: 10.1136/hrt.40.1.22.
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Perks W, Chatterjee S, Croxson R, Cruickshank J
Br J Clin Pharmacol. 1978; 5(2):101-6.
PMID: 339932
PMC: 1429247.
DOI: 10.1111/j.1365-2125.1978.tb01608.x.
Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082).
Boye N, VALE J
Eur J Clin Pharmacol. 1977; 11(1):11-4.
PMID: 319006
DOI: 10.1007/BF00561781.
Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
Roy P, Day L, Sowton E
Br Med J. 1975; 3(5977):195-7.
PMID: 238716
PMC: 1674130.
DOI: 10.1136/bmj.3.5977.195.
Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
Svendsen T, Hartling O, TRAP-JENSEN J
Eur J Clin Pharmacol. 1979; 15(4):223-8.
PMID: 38968
DOI: 10.1007/BF00618509.
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
Heel R, Brogden R, Speight T, Avery G
Drugs. 1979; 17(6):425-60.
PMID: 38096
DOI: 10.2165/00003495-197917060-00001.
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
HARMS H, Gooren L, SPOELSTRA A, Hesse C, Verschoor L
Br J Clin Pharmacol. 1978; 5(1):19-26.
PMID: 23133
PMC: 1429223.
DOI: 10.1111/j.1365-2125.1978.tb01593.x.
Side effects and contraindications of beta-receptor blocking agents.
LYDTIN H
Klin Wochenschr. 1977; 55(9):415-22.
PMID: 17766
DOI: 10.1007/BF01488578.
An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.
COMERFORD M, Besterman E
Postgrad Med J. 1976; 52(610):481-6.
PMID: 10564
PMC: 2496449.
DOI: 10.1136/pgmj.52.610.481.
